The Lancet HIV in conversation with

Janet Turan and Zachary Kwena on home-based couples testing and counselling for HIV Aug 26, 2026 1392 HIV remains underdiagnosed among men in many settings, contributing to ongoing transmission. When women seek care during pregnancy, there is an opportunity to reach out to their partners. Home-based couples testing and counselling can help to identify HIV and discuss other health issues. In this podcast, we look at a trial comparing lay counsellor delivered couples-based HIV testing with distribut

Amy Justice and Keri Althoff on the Lancet HIV Commission on ageing and HIV Jul 27, 2026 1365 Living longer with HIV is one of medicine's greatest success stories, but longevity brings new challenges. By 2040, more than half of all people living with HIV are expected to be over the age of 50, and their health pathways during ageing are very heterogeneous. What does that mean for patients, clinicians, and health systems worldwide? Are our health systems ready for this shift in the HIV agein

Annemarie Wensing, Tommaso Clemente, and Arjen Stam on clinical management of persistent low-level viremia in people on antiretroviral therapy Jul 1, 2026 1142 Some people on HIV treatment have a viral load that won't fully suppress. In this episode, we speak with Annemarie Wensing (University Medical Center Utrecht in The Netherlands and Witwatersrand University in South Africa), Aryen Stam (University Medical Center Utrecht) and Tomasso Clemente (IRCCS San Raffaele Scientific Institute in Milan, Itally); authors of an international consensus published

David Coelho and Arjee Restar on mental health disparities among transgender women and transfeminine people living with HIV Jun 15, 2026 1796 Transgender women and transfeminine people living with HIV face layers of stigma and multiple challengers that contribute to high levels of mental ill health and substance use—new research quantifies this burden, and we discuss the findings with the authors and explore drivers and solutions. Click here to read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)000

Esteban Martinez and Steven Grinspoon on non-communicable diseases and the REPRIEVE trial Apr 29, 2026 1554 Non-communicable diseases (NCDs) increasingly represent a leading cause of morbidity and mortality among people with HIV. People with HIV are at high risk of developing NCDs, often at younger ages and more severely than people without HIV. Esteban Martinez from the Hospital Clinic and University of Barcelona, and Steven Grinspoon from the Massachusetts General Hospital and Harvard Medical School,

Colette Smith on the Positive Voices UK survey recording health needs of people living with HIV Apr 2, 2026 839 People living with HIV often have many health needs beyond their antiretroviral medication. Editor in Chief Peter Hayward talks to Colette Smith of the Institute for Global Health at University College London about results of the Positive Voices survey identifying unmet health needs for people with HIV in the UK. Click here to read the full article: https://www.thelancet.com/journals/lanhiv/articl

Eran Shorer on Parkinsonism in people with virally suppressed HIV Mar 12, 2026 1164 Ageing with HIV brings new challenges. Even with effective ART, people ageing with HIV face increased risk of parkinsonism. Eran F Shorer from the Icahn School of Medicine at Mount Sinai joins us to explore the latest research on brain changes, motor slowing, and the need for better diagnosis and treatment. https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00262-0/fulltext Continu

Solange Baptiste, Charles Holmes, and Kenneth Ngure on sustainable HIV prevention in Africa Dec 10, 2025 2598 Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are joined in conversation by Solange Baptiste, Kenneth Ngure, and Charles Holmes, who worked extensively on

Luxena Sukumaran and Alan Winston on disordered sleep in people living with HIV Nov 27, 2025 1264 Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to help, and practical sleep hygiene tips for people living with HIV experiencing sleep disturbances. Click here to read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00221-8/fulltext Co

Deborah Persaud on the possibility of HIV remission in neonates Nov 5, 2025 2139 In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed to investigate that potential. We talk to a lead investigator about what we know so far. Read the full article: www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00189-4/fulltext Continue this conversation on socia

Jayne Ellis on cytomegalovirus and Epstein–Barr virus in people with HIV-associated cryptococcal meningitis Oct 2, 2025 1045 Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of Hygiene and Tropical Medicine discusses new research showing why targeting cytomegalovirus could be key to improving outcomes for people living with advanced HIV. Read the full article: https://www.thelancet.com/journals/lan

Maggie Walters and Michelle Bulterys on the probability of vertical transmission of HIV Aug 28, 2025 1113 Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle Bulterys talk us through their research into factors that affect the probability of vertical transmission and what it says about efforts to end new infant acquisitions. Read the full article: https://www.thelancet.com/journals/la

Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda Jul 31, 2025 1516 Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country. Read the full article: ht

Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV Jul 1, 2025 983 In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv Continue this conversation on so

Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV May 28, 2025 830 Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez in conversation with Grace Lui and Vincent Wong (The Chinese University of Hong Kong) as they discuss whether a dietary and exercise programme can reduce liver fat and induce resol

Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality May 1, 2025 1440 Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic? Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute (Melbourne, Australia) as they discuss their modelling study forecasting the effects of funding cuts on HIV acquisitions and mortality. Read the full article: https://

Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes Mar 28, 2025 1288 Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression. Read the article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv And the persona

Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women Mar 11, 2025 1382 Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding women. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on so

Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure Feb 5, 2025 1499 Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv Continue

Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish) Dec 5, 2024 2009 Please note: this podcast is entirely in Spanish Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra, Suiza) sobre los desafios a los que se enfrentan las poblaciones migrantes en el marco de la prevención y el tratamiento del VIH. Lea la Serie completa: https://www.thelancet.com/jou

Florence Riako Anam and Bruce Richman on U=U Nov 14, 2024 1553 Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to end AIDS as a public health threat. Read the full Article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00241-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_l

Peter Hayward on 10 years of The Lancet HIV Oct 1, 2024 1402 Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of The Lancet HIV. Read this month´s anniversary editorial here: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00245-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today

Salome Kuchukidze and Souleymane Diabaté on the link between intimate partner violence and vertical HIV transmission in sub-Saharan Africa Jul 23, 2024 1459 Salome Kuchukidze (McGill University, Canada) and Souleymane Diabaté (Université Laval) join Editor-in-Chief, Peter Hayward, to talk about links between intimate partner violence and vertical HIV transmission. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00148-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social!

José M. Zuniga on the future of urban HIV responses Commission Jul 21, 2024 1367 Adrian Gonzalez is joined by Jose M. Zuniga (IAPAC, Fast-Track Cities Institute) to talk about the IAPAC – Lancet HIV Commission on the future of urban HIV responses. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/

Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH en España (ES) Jul 1, 2024 1541 Adrian Gonzalez (Editor) entrevista Alejandro García García (Departamento de Enfermedades Infecciosas del Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de investigación Sanitaria en Madrid,España) sobre los avances en los tiempos de transición de las personas con VIH en España entre las distintas etapas de su vinculación a la atención médica, desde su diagnóstico hasta alcanzar la

Serge Eholie on treatments for HIV-2 Jun 6, 2024 1605 Professor Serge Eholie (PACCI Programme, Abidjan, Côte d’Ivoire) joins Peter Hayward to discuss a recent randomised trial of treatments for HIV-2 in Burkina Faso, Côte d’Ivoire, Senegal, and Togo. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00085-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us tod

Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana Apr 9, 2024 1333 Deputy Editor Adrian Gonzalez interviews Drew Voetsch (Division of Global HIV and TB, US Centers for Disease Control and Prevention, USA) and Robert Selato (National AIDS and Health Promotion Agency, Gaborone, Botswana) on Botswana´s accomplishments and progress towards achieving the UNAIDS 95 targets. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00003

Adam Trickey on trends in causes of death among people with HIV in Europe and North America Feb 27, 2024 718 Editor-in-Chief Peter Hayward is joined by Adam Trickey (University of Bristol, UK) to discuss a recent study looking at trends in causes of death among people with HIV in Europe and North America. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00272-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us to

Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK Jan 30, 2024 2511 Deputy Editor Adrian Gonzalez interviews Manik Kohli (Institute of Global Health at the University College London, UK), Iain Reeves (Homerton Healthcare NHS Trust, UK), and Laura Waters (Central and North West London NHS Trust, UK) on how homophobia results in limitations to accessing effective interventions such as HIV PrEP, mpox vaccination and DoxyPEP. Read the full article: https://www.thelan

Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women Nov 30, 2023 908 Deputy Editor Adrian Gonzalez interviews Lulu Nair (Stellenbosch University, South Africa), Connie Celum (University of Washington, USA), and Kenneth Ngure (Jomo Kenyatta University, Kenya) to discuss HIV prevention adherence and choice of the dapivirine vaginal ring and daily oral PrEP in adolescent girls and young women in Africa. Read the full article: https://www.thelancet.com/journals/lanhiv

Sophia Rein on HIV treatment with INSTIs and cardiovascular events Nov 2, 2023 915 Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https:/

Lawrence Mbuagbaw on reporting of HIV drug resistance in clinical studies using the CEDRIC-HIV checklist Oct 5, 2023 563 Deputy Editor Adrian Gonzalez interviews Lawrence Mbuagbaw (McMaster University, Ontario, Canada) about the CEDRIC-HIV checklist and its value in enhancing transparency, interpretation, comparability, and replicability of HIV drug resistance studies. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00173-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanh

Andreas Jahn and Nellie Wadonda-Kabondo on trends in HIV prevalence and incidence Sep 1, 2023 1454 We talk to Andreas Jahn (Malawi Ministry of Health) and Nellie Wadonda-Kabondo (US CDC, Lilongwe, Malawi) about trends in HIV prevalence and incidence derived from two successive PHIA studies, and Malawi's progress towards achieving 95-95-95 goal. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00144-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv

Eryn Braley and Mckenzie Braley on experiences of HIV among global Indigenous populations Aug 11, 2023 1280 Deputy Editor Adrian Gonzalez interviews Eryn Braley (Cree/settler, Saddle Lake Cree Nation, University of British Columbia) and Mckenzie Braley (Cree/settler, Saddle Lake Cree Nation, Simon Fraser University) to discuss about the unique perspective that Indigenous Peoples have on the HIV epidemic, and the interactions between Indigenous identities and HIV. Read the full article: https://www.thel

Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español) Jul 6, 2023 2707 Adrian Gonzalez (Deputy Editor) entrevista a Ricardo Luque (Oficina de Salud y Derechos Sexuales y Reproductivos del Ministerio de Salud y Protección Social, Colombia) y Miguel Barriga (Organización de base comunitaria "Red Somos", Colombia) sobre la situación sanitaria de los migrantes Venezolanos con VIH en Colombia. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2

Denton Callander on the effects of treatment as prevention Jun 2, 2023 1139 Peter Hayward is joined by Denton Callander (Sexual Health Programme, Kirby Institute, New South Wales, Australia) to discuss the effects of treatment as prevention on HIV epidemiology among men who have sex with men in Australia. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00050-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this con

Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women May 5, 2023 1565 Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=buzzsprout_icw_podcast_la

Yasmin Mohamed on early infant diagnosis of HIV Apr 13, 2023 1044 Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea. Read the full article: The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https:

Salome Kuchukhidze and Francisco Mbofana on intimate partner violence and women with HIV Feb 1, 2023 1366 Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade. Read the full article: The effects of

Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa Dec 14, 2022 1563 Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa. Read the full article: Relative cost-effectiveness of long-act

Helen Ayles and Musonda Simwinge on the PopART trial Nov 7, 2022 1773 Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV. Read the PopART trial papers: Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community Impact of universal testing an

Carol Strong and Stephane Ku on HIV and chemsex Sep 28, 2022 1064 Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex. Read the full Review: HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men Continue this conversation on social! Follow us today at... https://thelancet.bsky.soc

Elijah Kakande and Gabriel Chamie on TB interventions for people with HIV Aug 31, 2022 1281 Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda. Read the full article: A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Ugan

Amir Mohareb on PrEP and hepatitis B Jul 27, 2022 793 Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B. Read the full article: Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/the

Kenneth Ngure on PrEP in Kenya Jul 1, 2022 784 Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing. Read the full article: Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram

Marta Vasylyev and Casper Rokx on HIV care for displaced Ukranians Jun 1, 2022 1337 Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://f

Angela Colbers and Hylke Waalewijn on treatment for children with HIV May 3, 2022 1250 Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV. Read the full article: Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial Continue t

Nabila El-Bassel on intimate partner violence and HIV Mar 2, 2022 950 Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Amy Justice on ageing with HIV Feb 24, 2022 905 Dr Amy Justice (Yale University, USA) talks to Philippa Harris about the joint The Lancet HIV and The Lancet Healthy Longevity Series Ageing with HIV. Read the Series: Ageing with HIV Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet ht

Bridget Mugisa on the epidemiology of HIV in the Middle East and north Africa Feb 2, 2022 893 Peter Hayward talks to Dr Bridget Mugisa (WHO, Eastern Mediterranean Office, Egypt) about a study summarising the epidemiology of HIV in the Middle East and north Africa. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube

Aaloke Mody and Izukanji Sikazwe on universal HIV treatment in Zambia Nov 30, 2021 1323 Philippa Harris talks to Dr Aaloke Mody (Washington University School of Medicine, USA) and Izukanji Sikazwe (CIDRZ, Zambia) about their study on universal HIV treatment in Zambia. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00186-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.c

José Miro and Juliana Reyes on COVID-19 in people living with HIV Nov 2, 2021 1666 Prof José Miro (University of Barcelona) and Dr Juliana Reyes (Public Health Agency of Catalonia) speak to Editor-in-Chief Peter Hayward about SARS-CoV-2 and COVID-19 in people living with HIV. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00240-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https:/

Jon Shuter on smokers with HIV Sep 28, 2021 1499 Prof Jon Shuter (Albert Einstein College of Medicine, USA) talks to Dr Philippa Harris about harm reduction for smokers with HIV. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00156-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmed

Elizabeth Marie King on menopausal hormone therapy Sep 1, 2021 877 Peter Hayward talks to Dr Elizabeth Marie King (University of British Columbia, Canada) about a Viewpoint on menopausal hormone therapy for women living with HIV. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00148-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup h

John Frater on COVID-19 vaccination and HIV Aug 3, 2021 1196 John Frater (University of Oxford) talks to Deputy Editor Philippa Harris about COVID-19 and SARS-CoV-2 vaccination in people with HIV. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00103-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelanc

Elias Dah on PrEP in west Africa Jun 29, 2021 996 Dr Elias Dah (Institut National de Santé Publique, Centre Muraz, Bobo Dioulasso, Burkina Faso) joins Peter Hayward to discuss a PrEP implementation project in four countries in west Africa. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00005-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://in

Fatima Mir on the 2019 HIV outbreak in Pakistan Jun 2, 2021 1107 Fatima Mir (Aga Khan University, Pakistan) talks to Philippa Harris about the 2019 HIV outbreak in the Larkana District of Pakistan. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00049-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetm

Jessica Castilho and Claudia Cortes on HIV life expectancy in Latin America and the Caribbean Apr 27, 2021 795 Dr Jessica Castilho (Vanderbilt University Medical Centre) and Dr Claudia Cortes (University of Chile School of Medicine) join Peter Hayward to discuss their research on life expectancy for people living with HIV in Latin America and the Caribbean. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30358-1/fulltext Continue this conversation on social! Foll

Chloe Orkin on long-acting cabotegravir Mar 30, 2021 963 Professor Chloe Orkin (Queen Mary University London, UK) joins Peter Hayward to talk about long-acting cabotegravir for HIV treatment and the 96 weeks of the FLAIR study. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30340-4/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelance

Sarah Calabrese on U=U Mar 2, 2021 1040 Sarah Calabrese (George Washington University, USA) talks to Deputy Editor Philippa Harris about prioritising sexual pleasure and correcting misinformation in the era of U=U. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thel

Le Minh Giang and Todd Korthuis on opioid use disorder and HIV in Vietnam Feb 2, 2021 903 Le Minh Giang (Hanoi Medical University, Vietnam) and Todd Korthuis (Oregon Health and Science University, USA) discuss their work in Vietnam on treating opioid use disorder in people with HIV with Deputy Editor Philippa Harris. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30302-7/fulltext Continue this conversation on social! Follow us today at... htt

Michael Herce, Tonia Poteat, Ward van Bilsen and Hanne Zimmerman, and Jade Pagkas-Bather Dec 8, 2020 3214 In a bumper edition, we talk to contributors to several papers in the December issue on diverse topics that include test-and-treat in correctional facilities, PrEP engagement in transgender women, the burden of living with HIV in MSM, and gentrification in San Francisco. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup

Mathebe Kopo and Alain Amstutz on HIV testing and the HOSENG trial Oct 29, 2020 1678 Deputy Editor Philippa Harris discusses HIV testing and the HOSENG trial with researchers Mathebe Kopo (SolidarMed, Lesotho) and Alain Amstutz (Swiss Tropical and Public Health Institute, Basel, Switzerland). Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.c

Susannah Mayhew on integrating sexual health and HIV services Sep 30, 2020 823 Susannah Mayhew (London School of Hygiene and Tropical Medicine) joins Deputy Editor Philippa Harris to discuss integration of sexual and reproductive health and HIV services. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://yo

Ankur Gupta-Wright and Melanie Alufandika-Moyo on HIV drug resistance in Malawi Sep 4, 2020 915 Editor-in-Chief, Peter Hayward, talks to researchers from London School of Hygiene and Tropical Medicine and Melanie Alufandika-Moyo Malawi-Liverpool Wellcome Trust about their research on virological failure and HIV drug resistance in patients with HIV in hospital in Malawi. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetg

Di Gibb and Anna Turkova on dolutegravir for children with HIV Aug 5, 2020 1345 Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://face

Chi-Chi Udeagu on the impact of COVID-19 on HIV in NYC Jul 1, 2020 1502 Deputy Editor Philippa Harris talks to Chi-Chi Udeagu (New York City Department of Health and Mental Hygiene, USA) about HIV partner services in New York City and the impact of COVID-19. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet

Kelly Dooley and Gavin Churchyard on TB prevention in people with HIV Jun 4, 2020 929 Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/t

The London Patient on being cured of HIV May 4, 2020 2234 Adam Castillejo joins The Lancet HIV’s Editor, Peter Hayward, to talk about his experience of HIV, cancer, and becoming the second person to be cured of HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancet

Episodes

Recommended